Raising funds and sparking life-saving conversations
Read more about the amazing initiatives organised by our wonderful community, which not only raise critical funds for research, but also generate life-saving awareness.
Addressing fear of cancer recurrence
A study has been released investigating the effectiveness of a Melanoma Care Program for patients with early-stage melanoma with varying degrees of fear of cancer recurrence after treatment of their primary melanoma.
Global accuracy of MIA risk tool predicting sentinel node metastasis
The extensive global use of MIA’s online tool for estimating the risk of nodal metastasis in newly diagnosed melanoma patients has prompted an international study to validate its accuracy & improve its precision across diverse populations worldwide.
Leading MIA researchers and clinicians share latest advances in Athens
MIA researchers and clinicians attended the World Congress of Melanoma, held in conjunction with the EADO Congress, in Athens.
Early career fellowship for Dr Rebecca Simpson
MIA researcher Dr Rebecca Simpson has been awarded a CINSW 2024 Early Career Fellowship which supports early & mid-career researchers through the development of research & leadership skills & innovative approaches to research.
Big thanks to our Community Fundraisers!
A big thank you to our wonderful community of fundraisers. Your dedication and the stories behind your fundraising efforts are inspiring. We are so grateful for your support to help us reach zero deaths from melanoma.
First step to develop Roadmap for Targeted Skin Cancer Screening Program
We are excited to commence the work to develop the Roadmap for a National Targeted Skin Cancer Screening Program, and proud to be leading such an important endeavour for the Australian community.
World-first experimental cancer treatment paves way for clinical trial
Nature Medicine has published a peer-reviewed paper detailing the experimental glioblastoma cancer treatment developed by Professor Georgina Long AO, Medical Director of Melanoma Institute Australia, paving the way for a clinical trial to be conducted by researchers at The Brain Cancer Centre in Melbourne.
Fundraisers in our community go above and beyond
A heartfelt thank you to our incredible community of fundraisers. Your passion, dedication, and endless creativity never cease to inspire us. We are so grateful for your support!
From just 16 weeks’ survival to long term disease control
Newly released long-term data from a groundbreaking clinical trial for advanced melanoma patients whose disease had spread to their brain has proven that long-term disease control has been achieved for over 50% of patients given combination immunotherapy as first line treatment.